cancer of prostate	is a	malignancy
cancer of prostate	is a	urologic cancer
cancer of prostate	is a	solid tumor
cancer of prostate	is a	hormone‑dependent cancer
cancer of prostate	is a	common male cancer
cancer of prostate	is a	late‑stage disease
cancer of prostate	is a	treatable cancer
cancer of prostate	is a	localized cancer
cancer of prostate	is a	metastatic cancer
cancer of prostate	is a	PSA‑positive cancer
cancer of prostate	is diagnosed with	PSA test
cancer of prostate	is diagnosed with	digital rectal exam
cancer of prostate	is diagnosed with	prostate biopsy
cancer of prostate	is diagnosed with	MRI
cancer of prostate	is diagnosed with	CT scan
cancer of prostate	is diagnosed with	bone scan
cancer of prostate	is diagnosed with	transrectal ultrasound
cancer of prostate	is diagnosed with	multiparametric MRI
cancer of prostate	is diagnosed with	genomic testing
cancer of prostate	is staged by	Gleason score
cancer of prostate	is staged by	TNM staging
cancer of prostate	is staged by	PSA level
cancer of prostate	is staged by	clinical stage
cancer of prostate	is treated with	radical prostatectomy
cancer of prostate	is treated with	radiation therapy
cancer of prostate	is treated with	androgen deprivation therapy
cancer of prostate	is treated with	chemotherapy
cancer of prostate	is treated with	immunotherapy
cancer of prostate	is treated with	targeted therapy
cancer of prostate	is treated with	active surveillance
cancer of prostate	is treated with	cryotherapy
cancer of prostate	is treated with	high‑dose brachytherapy
cancer of prostate	is treated with	external beam radiation
radical prostatectomy	is a	surgical procedure
radical prostatectomy	is a	curative surgery
radical prostatectomy	is a	nerve‑sparing surgery
radical prostatectomy	is a	open surgery
radical prostatectomy	is a	robotic surgery
radiation therapy	is a	curative treatment
radiation therapy	is a	palliative treatment
radiation therapy	is a	external beam therapy
radiation therapy	is a	brachytherapy
radiation therapy	is a	hypofractionated therapy
androgen deprivation therapy	is a	hormonal therapy
androgen deprivation therapy	is a	luteinizing hormone‑releasing hormone agonist
androgen deprivation therapy	is a	anti‑androgen
androgen deprivation therapy	is a	orchiectomy
chemotherapy	is a	cytotoxic therapy
chemotherapy	is a	docetaxel
chemotherapy	is a	cabazitaxel
immunotherapy	is a	checkpoint inhibitor
immunotherapy	is a	vaccine
immunotherapy	is a	adoptive cell therapy
targeted therapy	is a	PARP inhibitor
targeted therapy	is a	PI3K inhibitor
targeted therapy	is a	androgen receptor inhibitor
active surveillance	is a	watchful waiting
active surveillance	is a	periodic PSA monitoring
active surveillance	is a	repeat biopsy
cryotherapy	is a	cryoablation
cryotherapy	is a	percutaneous procedure
high‑dose brachytherapy	is a	seed implantation
high‑dose brachytherapy	is a	iodine‑125 seeds
external beam radiation	is a	3‑D conformal therapy
external beam radiation	is a	intensity‑modulated therapy
cancer of prostate	has risk factor	age
cancer of prostate	has risk factor	family history
cancer of prostate	has risk factor	African‑American ethnicity
cancer of prostate	has risk factor	obesity
cancer of prostate	has risk factor	diet
cancer of prostate	has risk factor	smoking
cancer of prostate	has risk factor	high‑fat diet
cancer of prostate	has risk factor	low‑vitamin D
cancer of prostate	has symptom	urinary frequency
cancer of prostate	has symptom	weak stream
cancer of prostate	has symptom	hematuria
cancer of prostate	has symptom	bone pain
cancer of prostate	has symptom	erectile dysfunction
cancer of prostate	has symptom	weight loss
cancer of prostate	is associated with	bone metastasis
cancer of prostate	is associated with	lymph node metastasis
cancer of prostate	is associated with	visceral metastasis
bone metastasis	leads to	bone pain
bone metastasis	leads to	pathological fracture
bone metastasis	leads to	hypercalcemia
lymph node metastasis	leads to	regional spread
lymph node metastasis	leads to	systemic spread
visceral metastasis	leads to	liver involvement
visceral metastasis	leads to	lung involvement
cancer of prostate	predicts	mortality
cancer of prostate	predicts	readmission
cancer of prostate	predicts	progression
cancer of prostate	predicts	recurrence
PSA level	predicts	recurrence
Gleason score	predicts	aggressiveness
TNM stage	predicts	survival
genomic risk score	predicts	treatment response
radical prostatectomy	reduces	recurrence risk
radiation therapy	reduces	local recurrence
androgen deprivation therapy	reduces	progression risk
